A number of firms have modified their ratings and price targets on shares of Perrigo (NYSE: PRGO) recently:

  • 11/16/2018 – Perrigo was upgraded by analysts at ValuEngine from a “strong sell” rating to a “sell” rating.
  • 11/14/2018 – Perrigo had its price target lowered by analysts at Wells Fargo & Co from $77.00 to $64.00. They now have a “market perform” rating on the stock.
  • 11/13/2018 – Perrigo had its price target lowered by analysts at Morgan Stanley from $77.00 to $67.00. They now have a “hold” rating on the stock.
  • 11/13/2018 – Perrigo was downgraded by analysts at Berenberg Bank from a “buy” rating to a “hold” rating. They now have a $72.00 price target on the stock, down previously from $100.00.
  • 11/9/2018 – Perrigo was given a new $63.00 price target on by analysts at Royal Bank of Canada. They now have a “hold” rating on the stock.
  • 11/8/2018 – Perrigo was downgraded by analysts at ValuEngine from a “sell” rating to a “strong sell” rating.
  • 10/8/2018 – Perrigo had its “buy” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $107.00 price target on the stock. They wrote, “We rate PRGO Overweight and have a 12-month price target of $107. Perrigo has been through a lot over the past two years, but we think the Street can finally refocus on fundamentals. This should drive a greater appreciation for the company’s growth prospects and earnings potential, in our view. Valuation Summary We use a blend of DCF and multiples (EV/EBITDA) analysis to get to our 12-month price target of $107.””
  • 10/6/2018 – Perrigo was upgraded by analysts at ValuEngine from a “strong sell” rating to a “sell” rating.

NYSE PRGO traded down $1.61 on Tuesday, hitting $61.18. 64,161 shares of the company were exchanged, compared to its average volume of 1,722,774. The company has a current ratio of 1.85, a quick ratio of 1.26 and a debt-to-equity ratio of 0.54. The company has a market cap of $8.60 billion, a PE ratio of 12.41, a PEG ratio of 2.02 and a beta of 0.66. Perrigo Company PLC has a twelve month low of $62.32 and a twelve month high of $95.93.

Perrigo (NYSE:PRGO) last posted its quarterly earnings data on Thursday, November 8th. The company reported $1.09 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.05 by $0.04. The firm had revenue of $1.13 billion for the quarter, compared to the consensus estimate of $1.17 billion. Perrigo had a return on equity of 11.32% and a net margin of 2.54%. The business’s revenue for the quarter was down 8.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.39 EPS. Research analysts forecast that Perrigo Company PLC will post 4.55 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 18th. Shareholders of record on Friday, November 30th will be issued a dividend of $0.19 per share. The ex-dividend date of this dividend is Thursday, November 29th. This represents a $0.76 annualized dividend and a yield of 1.24%. Perrigo’s payout ratio is presently 15.42%.

In other Perrigo news, EVP Svend Andersen bought 3,900 shares of the company’s stock in a transaction dated Friday, November 9th. The shares were bought at an average price of $63.01 per share, for a total transaction of $245,739.00. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Murray S. Kessler bought 15,683 shares of the company’s stock in a transaction dated Friday, November 9th. The stock was acquired at an average price of $63.79 per share, for a total transaction of $1,000,418.57. Following the acquisition, the chief executive officer now directly owns 13,416 shares in the company, valued at $855,806.64. The disclosure for this purchase can be found here. In the last 90 days, insiders have acquired 25,783 shares of company stock worth $1,646,976. Corporate insiders own 6.90% of the company’s stock.

Several institutional investors and hedge funds have recently modified their holdings of the company. Dupont Capital Management Corp increased its holdings in shares of Perrigo by 63.8% in the 2nd quarter. Dupont Capital Management Corp now owns 1,705 shares of the company’s stock valued at $124,000 after purchasing an additional 664 shares during the period. Nissay Asset Management Corp Japan ADV increased its holdings in Perrigo by 8.6% in the second quarter. Nissay Asset Management Corp Japan ADV now owns 11,106 shares of the company’s stock worth $810,000 after buying an additional 880 shares during the last quarter. Tower Research Capital LLC TRC increased its holdings in Perrigo by 35.0% in the second quarter. Tower Research Capital LLC TRC now owns 3,590 shares of the company’s stock worth $262,000 after buying an additional 930 shares during the last quarter. Penserra Capital Management LLC increased its holdings in Perrigo by 16.5% in the third quarter. Penserra Capital Management LLC now owns 6,900 shares of the company’s stock worth $488,000 after buying an additional 975 shares during the last quarter. Finally, Cullen Frost Bankers Inc. increased its holdings in Perrigo by 1.2% in the third quarter. Cullen Frost Bankers Inc. now owns 92,064 shares of the company’s stock worth $6,518,000 after buying an additional 1,048 shares during the last quarter. Institutional investors own 90.08% of the company’s stock.

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.

See Also: Book Value Per Share – BVPS

Receive News & Ratings for Perrigo Company PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo Company PLC and related companies with MarketBeat.com's FREE daily email newsletter.